Loading...
|
ab74076 |
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Products:Signal Transduction >> Cytoskeleton / ECM >> Cytoskeleton >> Microfilaments >> Actin etc >> Actin Binding Proteins
Anti-Vinculin antibody
See all Vinculin products (14) ...
Rabbit polyclonal to Vinculin
WB, Flow Cytmore details
Reacts with
Mouse, Rat, Human
Predicted to work with
Horse, Chicken, Cow, Pig, Chimpanzee, Zebrafish, Rhesus monkey, Zebra finch
Synthetic peptide conjugated to KLH derived from within residues 1100 to the C-terminus of Human Vinculin.
(Peptide available as ab74076.)
This antibody gave a positive signal in the following Lysates: Mouse Kidney Tissue, EBS E14 TG2A Day 3 Whole Cell, HepG2 Whole Cell, Human Small Intestine Tissue, Human Skeletal Muscle Tissue, Rat Liver Tissue, Mouse Pancreas Tissue (data not shown)
Liquid
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Preservative: 0.02% Sodium Azide
Constituents: 1% BSA, PBS, pH 7.4
Concentration information loading...
Immunogen affinity purified
Polyclonal
IgG
Cardiovascular >> Heart >> Contractility >> Contractile Proteins >> Actins
Cardiovascular >> Heart >> Cardiac arrhythmias
Signal Transduction >> Cytoskeleton / ECM >> Cytoskeleton >> Microfilaments >> Actin etc >> Actin Binding Proteins
Our Abpromise guarantee covers the use of ab73412 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
WB: Use a concentration of 1 µg/mlDetects a band of approximately 130 kDa (predicted molecular weight: 124 kDa).
Flow Cyt: Use at an assay dependent concentration.
Actin filament (F-actin)-binding protein involved in cell-matrix adhesion and cell-cell adhesion. Regulates cell-surface E-cadherin expression and potentiates mechanosensing by the E-cadherin complex. May also play important roles in cell morphology and locomotion.
Metavinculin is muscle-specific.
Defects in VCL are the cause of cardiomyopathy dilated type 1W (CMD1W) [MIM:611407]. Dilated cardiomyopathy is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.
Defects in VCL are the cause of cardiomyopathy familial hypertrophic type 15 (CMH15) [MIM:613255]. It is a hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death.
Belongs to the vinculin/alpha-catenin family.
Exists in at least two conformations. When in the closed, 'inactive' conformation, extensive interactions between the head and tail domains prevent detectable binding to most of its ligands. It takes on an 'active' conformation after cooperative and simultaneous binding of two different ligands. This activation involves displacement of the head-tail interactions and leads to a significant accumulation of ternary complexes. The active form then binds a number of proteins that have both signaling and structural roles that are essential for cell adhesion.
The N-terminal globular head (Vh) comprises of subdomains D1-D4. The C-terminal tail (Vt) binds F-actin and cross-links actin filaments into bundles. An intramolecular interaction between Vh and Vt masks the F-actin-binding domain located in Vt. The binding of talin and alpha-actinin to the D1 subdomain of vinculin induces a helical bundle conversion of this subdomain, leading to the disruption of the intramolecular interaction and the exposure of the cryptic F-actin-binding domain of Vt. Vt inhibits actin filament barbed end elongation without affecting the critical concentration of actin assembly.
Phosphorylated; on serines, threonines and tyrosines. Phosphorylation on Tyr-1133 in activated platelets affects head-tail interactions and cell spreading but has no effect on actin binding nor on localization to focal adhesion plaques.
Aceylated; mainly by myristic acid but also small amount of palmitic acid.
Cytoplasm > cytoskeleton. Cell junction > adherens junction. Cell membrane. Cytoplasmic face of adhesion plaques. Recruitment to cell-cell junctions occurs in a myosin II-dependent manner. Interaction with CTNNB1 is necessary for its localization to the cell-cell junctions.
Target information above from: UniProt accessionP18206
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
Western blot - Vinculin antibody (ab73412)

All lanes : Anti-Vinculin antibody (ab73412) at 1 µg/ml
Lane 1 : Kidney (Mouse) Tissue Lysate
Lane 2 : EBS E14 TG2A Day 3 (Mouse Pluripotent Embryonic Stem Cell) Whole Cell Lysate
Lane 3 : HepG2 (Human hepatocellular liver carcinoma cell line) Whole Cell Lysate
Lane 4 : Small Intestine (Human) Tissue Lysate - adult normal tissue (ab29276)
Lane 5 : Skeletal Muscle (Human) Tissue Lysate - adult normal tissue (ab29330)
Lane 6 : Liver (Rat) Tissue Lysate
Lysates/proteins at 10 µg per lane.
Secondary
Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution
developed using the ECL technique
Performed under reducing conditions.
Predicted band size : 124 kDa
Observed band size : 130 kDa (why is the actual band size different from the predicted?)
Exposure time : 2 minutes
Flow Cytometry - Vinculin antibody (ab73412)

ab73412 staining vinculin in Human platelet cells by Flow cytometry.
Cells were fixed in paraformaldehyde and permeabilized using 0.1% Triton-X-100 in 2% BSA for 15 minutes. Primary antibody used at a 1/250 dilution and incubated for 16 hours at 4°C. The secondary antibody used was an Alexa Fluor®488 conjugated chicken anti-rabbit IgG (H+L) at a 1/500 dilution.
Image courtesy of an anonymous Abreview.
Western blot - Anti-Vinculin antibody (ab73412)

Anti-Vinculin antibody (ab73412) at 1/1500 dilution + whole cell lysate prepared from human platelets (treated with ADP for 30 minutes) at 20 µg
Secondary
HRP conjugated goat anti-rabbit polyclonal at 1/10000 dilution
developed using the ECL technique
Predicted band size : 124 kDa
Exposure time : 1 minute
Blocked with 5% milk for 1 hour at 22°C.
Image courtesy of Dr Mahesh Shivananjappa by Abreview.
ab73412 has not yet been referenced specifically in any publications.
Publishing research using ab73412? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:

All lanes : Anti-Vinculin antibody (ab73412) at 1 µg/ml
Lane 1 : Kidney (Mouse) Tissue Lysate
Lane 2 : EBS E14 TG2A Day 3 (Mouse Pluripotent Embryonic Stem Cell) Whole Cell Lysate
Lane 3 : HepG2 (Human hepatocellular liver carcinoma cell line) Whole Cell Lysate
Lane 4 : Small Intestine (Human) Tissue Lysate - adult normal tissue (ab29276)
Lane 5 : Skeletal Muscle (Human) Tissue Lysate - adult normal tissue (ab29330)
Lane 6 : Liver (Rat) Tissue Lysate
Lysates/proteins at 10 µg per lane.
Secondary
Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution
developed using the ECL technique
Performed under reducing conditions.
Predicted band size : 124 kDa
Observed band size : 130 kDa (why is the actual band size different from the predicted?)
Exposure time : 2 minutes

ab73412 staining vinculin in Human platelet cells by Flow cytometry.
Cells were fixed in paraformaldehyde and permeabilized using 0.1% Triton-X-100 in 2% BSA for 15 minutes. Primary antibody used at a 1/250 dilution and incubated for 16 hours at 4°C. The secondary antibody used was an Alexa Fluor®488 conjugated chicken anti-rabbit IgG (H+L) at a 1/500 dilution.
Image courtesy of an anonymous Abreview.

Anti-Vinculin antibody (ab73412) at 1/1500 dilution + whole cell lysate prepared from human platelets (treated with ADP for 30 minutes) at 20 µg
Secondary
HRP conjugated goat anti-rabbit polyclonal at 1/10000 dilution
developed using the ECL technique
Predicted band size : 124 kDa
Exposure time : 1 minute
Blocked with 5% milk for 1 hour at 22°C.
Image courtesy of Dr Mahesh Shivananjappa by Abreview.
2
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
